Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 308
6
Diseases
27
Unique genes
0.157
Avg. similarity score
Epiphyseal dysplasia
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epiphyseal dysplasia
Marshall syndrome
Stickler syndrome
Stickler syndrome, type 4
Comp-related skeletal dysplasia
Laryngeal hypoplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Epiphyseal dysplasia | 5 | 5 | 10 |
| Marshall syndrome | 3 | 3 | 19 |
| Stickler syndrome | 3 | 3 | 14 |
| Stickler syndrome, type 4 | 3 | 3 | 1 |
| Comp-related skeletal dysplasia | 1 | 1 | 1 |
| Laryngeal hypoplasia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL9A1 | 4 / 6 | Epiphyseal dysplasia, Marshall syndrome, Stickler syndrome, Stickler syndrome, type 4 |
| COL2A1 | 3 / 6 | Epiphyseal dysplasia, Marshall syndrome, Stickler syndrome |
| COL9A2 | 3 / 6 | Epiphyseal dysplasia, Marshall syndrome, Stickler syndrome |
| COL9A3 | 3 / 6 | Epiphyseal dysplasia, Marshall syndrome, Stickler syndrome |
| BMP4 | 2 / 6 | Marshall syndrome, Stickler syndrome |
| COL11A1 | 2 / 6 | Marshall syndrome, Stickler syndrome |
| COL11A2 | 2 / 6 | Marshall syndrome, Stickler syndrome |
| COL1A1 | 2 / 6 | Epiphyseal dysplasia, Stickler syndrome |
| COMP | 2 / 6 | Comp-related skeletal dysplasia, Epiphyseal dysplasia |
| FOXP4 | 2 / 6 | Epiphyseal dysplasia, Laryngeal hypoplasia |
| LOXL3 | 2 / 6 | Marshall syndrome, Stickler syndrome |
| LRP2 | 2 / 6 | Marshall syndrome, Stickler syndrome |
| SLC26A2 | 2 / 6 | Epiphyseal dysplasia, Marshall syndrome |
| VCAN | 2 / 6 | Marshall syndrome, Stickler syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Collagen biosynthesis and modifying enzymes | Reactome | 10 / 67 | 66.4× | 1.13e-16 | 5.07e-14 ✓ sig. |
| Collagen chain trimerization | Reactome | 8 / 44 | 80.9× | 3.49e-14 | 9.71e-12 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 8 / 51 | 69.8× | 1.24e-13 | 3.10e-11 ✓ sig. |
| ECM proteoglycans | Reactome | 8 / 51 | 69.8× | 1.24e-13 | 3.10e-11 ✓ sig. |
| Protein digestion and absorption | KEGG | 9 / 103 | 38.9× | 7.25e-13 | 1.62e-10 ✓ sig. |
| Integrin cell surface interactions | Reactome | 7 / 81 | 38.4× | 3.88e-10 | 4.86e-8 ✓ sig. |
| ECM-receptor interaction | KEGG | 7 / 89 | 35.0× | 7.60e-10 | 8.77e-8 ✓ sig. |
| NCAM1 interactions | Reactome | 5 / 21 | 106× | 7.71e-10 | 8.86e-8 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 9 / 232 | 17.3× | 1.11e-9 | 1.24e-7 ✓ sig. |
| Non-integrin membrane-ECM interactions | Reactome | 5 / 24 | 92.7× | 1.60e-9 | 1.69e-7 ✓ sig. |
| Signaling by PDGF | Reactome | 5 / 33 | 67.4× | 8.82e-9 | 7.84e-7 ✓ sig. |
| Collagen degradation | Reactome | 5 / 52 | 42.8× | 9.39e-8 | 6.20e-6 ✓ sig. |
| Focal adhesion | KEGG | 7 / 203 | 15.3× | 2.37e-7 | 1.39e-5 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 4 / 30 | 59.3× | 5.33e-7 | 2.83e-5 ✓ sig. |
| Extracellular matrix organization | Reactome | 3 / 15 | 89.0× | 4.53e-6 | 1.75e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| collagen fibril organization | GO:0030199 | 7 / 65 | 74.5× | 3.71e-12 | 1.49e-9 ✓ sig. |
| skeletal system development | GO:0001501 | 8 / 151 | 36.7× | 2.94e-11 | 9.57e-9 ✓ sig. |
| sensory perception of sound | GO:0007605 | 8 / 162 | 34.2× | 5.17e-11 | 1.59e-8 ✓ sig. |
| cartilage development | GO:0051216 | 6 / 89 | 46.7× | 2.69e-9 | 5.36e-7 ✓ sig. |
| inner ear morphogenesis | GO:0042472 | 4 / 65 | 42.6× | 2.20e-6 | 1.56e-4 ✓ sig. |
| endochondral ossification | GO:0001958 | 3 / 31 | 67.0× | 1.18e-5 | 5.92e-4 ✓ sig. |
| tendon development | GO:0035989 | 2 / 4 | 346× | 1.20e-5 | 6.02e-4 ✓ sig. |
| visual perception | GO:0007601 | 5 / 215 | 16.1× | 1.26e-5 | 6.27e-4 ✓ sig. |
| ossification | GO:0001503 | 4 / 110 | 25.2× | 1.80e-5 | 8.24e-4 ✓ sig. |
| skeletal system morphogenesis | GO:0048705 | 3 / 45 | 46.1× | 3.67e-5 | 1.43e-3 ✓ sig. |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 2 / 9 | 154× | 7.19e-5 | 2.36e-3 ✓ sig. |
| heart morphogenesis | GO:0003007 | 3 / 61 | 34.0× | 9.15e-5 | 2.83e-3 ✓ sig. |
| chondrocyte differentiation | GO:0002062 | 3 / 61 | 34.0× | 9.15e-5 | 2.83e-3 ✓ sig. |
| proteoglycan metabolic process | GO:0006029 | 2 / 11 | 126× | 1.10e-4 | 3.23e-3 ✓ sig. |
| embryonic skeletal joint morphogenesis | GO:0060272 | 2 / 11 | 126× | 1.10e-4 | 3.23e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Marshall syndrome | Stickler syndrome | 0.417 | 10 | 4.48e-28 | 1.35e-26 ✓ sig. |
| Epiphyseal dysplasia | Stickler syndrome | 0.250 | 5 | 6.98e-14 | 9.66e-13 ✓ sig. |
| Epiphyseal dysplasia | Marshall syndrome | 0.200 | 5 | 4.05e-13 | 5.37e-12 ✓ sig. |
| Comp-related skeletal dysplasia | Epiphyseal dysplasia | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Epiphyseal dysplasia | Laryngeal hypoplasia | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Epiphyseal dysplasia | Stickler syndrome, type 4 | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Stickler syndrome | Stickler syndrome, type 4 | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Marshall syndrome | Stickler syndrome, type 4 | 0.050 | 1 | 1.23e-3 | 1.97e-3 ✓ sig. |